Annual EBITDA
$1.08B$255.98M+31.24%
Summary
- Current Value
- As of today, GMAB annual EBITDA is $1.08B, up +31.24% on
- Historical Performance
- GMAB annual EBITDA is up +107.07% over the past 3 years, and up +158.35% over the past 5 years
- All-Time High Comparison
- GMAB annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- GMAB annual EBITDA is +31.24% above its 3-year low of $819.51M reached on
- Sector Comparison
- GMAB annual EBITDA is higher than 93.89% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $1.08B | +31.2% | +107.1% | +158.3% | +1551.0% | |
| Quarterly EBITDA | $474.90M | +44.6% | – | +248.5% | +1465.5% | |
| TTM EBITDA | $1.39B | +140.9% | – | +22.3% | +10000.0% | |
| Price | $33.85 | +67.3% | -15.7% | -23.8% | +2407.4% | |
| PE Ratio | 14.38 | +24.5% | -58.2% | -64.9% | – | |
| Annual Revenue | $3.12B | +30.6% | +131.6% | +288.1% | +2625.3% | |
| Annual EPS | $1.76 | +83.7% | +143.2% | +245.0% | +517.1% | |
| Annual EBIT | $1.02B | +31.5% | +111.7% | +156.8% | +1394.2% | |
| Annual Net Income | $1.14B | +80.2% | +137.9% | +250.3% | +1844.4% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.08B | at high | |
| 5Y | $1.08B | at high | |
| All | $1.08B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $819.51M | +31.2% | |
| 5Y | $519.39M | +107.1% | |
| All | -$137.28M | +883.4% |
EBITDA History
FAQ
What is the current annual EBITDA of GMAB?
As of today, GMAB annual EBITDA is $1.08B
What is 1-year change in GMAB annual EBITDA?
GMAB annual EBITDA is up +31.24% year-over-year
What is 3-year change in GMAB annual EBITDA?
GMAB annual EBITDA is up +107.07% over the past 3 years
How far is GMAB annual EBITDA from its all-time high?
GMAB annual EBITDA is currently at its all-time high
How does GMAB annual EBITDA rank versus sector peers?
GMAB annual EBITDA is higher than 93.89% of companies in Healthcare sector
When is GMAB next annual earnings release?
The next annual earnings release for GMAB is on
Quarterly EBITDA
$474.90M$94.09M+24.71%
Summary
- Current Value
- As of today, GMAB quarterly EBITDA is $474.90M, up +24.71% on
- Historical Performance
- GMAB quarterly EBITDA is up +44.63% year-over-year, with unknown 3-year change
- All-Time High Comparison
- GMAB quarterly EBITDA is currently -28.61% below its historical high of $665.22M set on
- 3-Year Low Comparison
- GMAB quarterly EBITDA is +132.64% above its 3-year low of $204.14M reached on
- Sector Comparison
- GMAB quarterly EBITDA is higher than 95.12% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $474.90M | +24.7% | +44.6% | – | +248.5% | |
| Annual EBITDA | $1.08B | – | +31.2% | +107.1% | +158.3% | |
| TTM EBITDA | $1.39B | +11.8% | +140.9% | – | +22.3% | |
| Price | $33.85 | +3.5% | +67.3% | -15.7% | -23.8% | |
| PE Ratio | 14.38 | +3.5% | +24.5% | -58.2% | -64.9% | |
| Quarterly Revenue | $1.02B | +8.6% | +24.7% | +84.0% | +275.9% | |
| Quarterly EPS | $0.64 | +16.3% | +120.5% | +21.3% | +409.6% | |
| Quarterly EBIT | $479.85M | +31.6% | +53.8% | +83.6% | +256.2% | |
| Quarterly Net Income | $399.21M | +17.3% | +114.2% | +14.3% | +379.8% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $474.90M | at high | |
| 3Y | $474.90M | at high | |
| 5Y | $474.90M | at high | |
| All | $665.22M | -28.6% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $204.14M | +132.6% | |
| 3Y | $204.14M | +132.6% | |
| 5Y | $143.84M | N/A | +230.2% |
| All | -$59.21M | +902.1% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of GMAB?
As of today, GMAB quarterly EBITDA is $474.90M
What is GMAB quarterly EBITDA most recent change?
GMAB quarterly EBITDA was up +24.71% on September 30, 2025
What is 1-year change in GMAB quarterly EBITDA?
GMAB quarterly EBITDA is up +44.63% year-over-year
How far is GMAB quarterly EBITDA from its all-time high?
GMAB quarterly EBITDA is currently -28.61% below its historical high of $665.22M set on June 30, 2020
How does GMAB quarterly EBITDA rank versus sector peers?
GMAB quarterly EBITDA is higher than 95.12% of companies in Healthcare sector
When is GMAB next earnings release?
The next earnings release for GMAB is on
TTM EBITDA
$1.39B$146.54M+11.78%
Summary
- Current Value
- As of today, GMAB TTM EBITDA is $1.39B, up +11.78% on
- Historical Performance
- GMAB TTM EBITDA is up +140.89% year-over-year, with unknown 3-year change
- All-Time High Comparison
- GMAB TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- GMAB TTM EBITDA is +437.89% above its 3-year low of $258.44M reached on
- Sector Comparison
- GMAB TTM EBITDA is higher than 94.21% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $1.39B | +11.8% | +140.9% | – | +22.3% | |
| Annual EBITDA | $1.08B | – | +31.2% | +107.1% | +158.3% | |
| Quarterly EBITDA | $474.90M | +24.7% | +44.6% | – | +248.5% | |
| Price | $33.85 | +3.5% | +67.3% | -15.7% | -23.8% | |
| PE Ratio | 14.38 | +3.5% | +24.5% | -58.2% | -64.9% | |
| TTM Revenue | $3.59B | +6.0% | +25.0% | +107.9% | +118.2% | |
| TTM EPS | $2.35 | +17.5% | +126.8% | +94.2% | +83.8% | |
| TTM EBIT | $1.35B | +14.3% | +44.5% | +109.8% | +18.9% | |
| TTM Net Income | $1.48B | +16.7% | +120.0% | +85.5% | +76.8% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.39B | at high | |
| 3Y | $1.39B | at high | |
| 5Y | $1.39B | at high | |
| All | $1.39B | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $658.63M | N/A | +111.1% |
| 3Y | $258.44M | +437.9% | |
| 5Y | $258.44M | +437.9% | |
| All | -$153.23M | +1007.2% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of GMAB?
As of today, GMAB TTM EBITDA is $1.39B
What is GMAB TTM EBITDA most recent change?
GMAB TTM EBITDA was up +11.78% on September 30, 2025
What is 1-year change in GMAB TTM EBITDA?
GMAB TTM EBITDA is up +140.89% year-over-year
How far is GMAB TTM EBITDA from its all-time high?
GMAB TTM EBITDA is currently at its all-time high
How does GMAB TTM EBITDA rank versus sector peers?
GMAB TTM EBITDA is higher than 94.21% of companies in Healthcare sector
When is GMAB next earnings release?
The next earnings release for GMAB is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- GMAB Official Website www.genmab.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1434265/000143426525000092/0001434265-25-000092-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1434265/000155837025000846/0001558370-25-000846-index.htm
- GMAB Profile on Yahoo Finance finance.yahoo.com/quote/GMAB
- GMAB Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gmab